Expertise in
11
conditions

Dr. Raymond L. Benza

Cardiology
600 Gresham Drive, 
Norfolk, VA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
11
conditions
600 Gresham Drive, 
Norfolk, VA 

Overview

Raymond Benza is a Cardiologist practicing medicine in Norfolk, Virginia.

Dr. Benza is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Heart Failure, Heart Transplant, and Aortic Valve Replacement.

Dr. Benza is board certified in American Board Of Internal Medicine - Advanced Heart Failure And Transplant Cardiology - 2027. He is actively involved in clinical research, co-authoring 210 peer reviewed articles and participating in 8 clinical trials. Dr. Benza is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in NY

Board Certifications

American Board Of Internal Medicine - Advanced Heart Failure And Transplant Cardiology - 2027

Fellowships

University of Alabama Hospital - 1997

Hospital Affiliations

Sentara Norfolk General Hospital
Sentara Leigh Hospital
Sentara Careplex Hospital
Sentara Medical Group

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Sentara Advanced Heart Failure Center
600 Gresham Drive, Norfolk, VA 23507

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Pulmonary Hypertension Association Registry
Pulmonary Hypertension Association Registry
Enrollment Status: Recruiting
Publish Date: November 14, 2025
Hemodynamic-GUIDEd Management of Heart Failure
Hemodynamic-GUIDEd Management of Heart Failure
Enrollment Status: Completed
Publish Date: August 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach
Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach
Enrollment Status: Withdrawn
Publish Date: June 06, 2023
Intervention Type: Drug
Study Drug: Treprostinil Diolamine
Study Phase: Phase 2
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
Pharmacogenomics in Pulmonary Arterial Hypertension: A Multi-Center International Study to Determine Whether in PAH Patients Clinical Associations Exist Between the Efficacy and Toxicity of Endothelin Receptor Antagonists and Several Gene Polymorphisms in Several Key Disease-Specific and Therapy Specific Genes
Pharmacogenomics in Pulmonary Arterial Hypertension: A Multi-Center International Study to Determine Whether in PAH Patients Clinical Associations Exist Between the Efficacy and Toxicity of Endothelin Receptor Antagonists and Several Gene Polymorphisms in Several Key Disease-Specific and Therapy Specific Genes
Enrollment Status: Withdrawn
Publish Date: December 09, 2021
Intervention Type: Drug
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Dose Titration Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046, A Sustained-Release Analogue of Vasoactive Intestinal Peptide, In Adult Subjects With Pulmonary Arterial Hypertension
An Open-Label, Dose Titration Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046, A Sustained-Release Analogue of Vasoactive Intestinal Peptide, In Adult Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: October 08, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

210 Total Publications

The Pediatric Pulmonary Hypertension International Risk Score: A Prediction Model for Outcomes Using Machine Learning.
The Pediatric Pulmonary Hypertension International Risk Score: A Prediction Model for Outcomes Using Machine Learning.
Journal: Circulation
Published: August 11, 2026
Similar Doctors
Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
 (8.6 miles away)
757-490-4802
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Rick Nishimura is a Cardiologist practicing medicine in Virginia Beach, Virginia. Dr. Nishimura is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Mitral Stenosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Nishimura is currently accepting new patients.

Expertise in
22
conditions
Dr. Rajiv Gulati
Cardiology | Pulmonary Medicine
Expertise in
22
conditions
Dr. Rajiv Gulati
Cardiology | Pulmonary Medicine
Referral may be required

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
 (8.6 miles away)
757-490-4802
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Rajiv Gulati is a Cardiologist and a Pulmonary Medicine provider practicing medicine in Virginia Beach, Virginia. Dr. Gulati is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Spontaneous Coronary Artery Dissection (SCAD), Heart Attack, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Aortic Valve Replacement. Dr. Gulati is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request

Riverside Cardiology Specialists Newport News

12200 Warwick Boulevard, 590 B, 
Newport News, VA 
 (15.6 miles away)
757-594-2074
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Kramer is a Cardiologist practicing medicine in Newport News, Virginia. Dr. Kramer is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Peripheral Artery Disease, Heart Transplant, and Cardiac Ablation. Dr. Kramer is board certified in American Board Of Internal Medicine - Internal Medicine and American Board Of Internal Medicine - Cardiovascular Disease. Dr. Kramer is currently accepting new patients.

Frequently Asked Questions about Dr. Raymond L. Benza

How do I make an appointment with Dr. Raymond L. Benza?

You can book an appointment with Dr. Raymond L. Benza by calling their office at 757-388-2831. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Raymond L. Benza a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Raymond L. Benza is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Raymond L. Benza specialize in?

While Dr. Raymond L. Benza is a Cardiology, they have specific expertise in Pulmonary Hypertension, Hypertension, and Heart Failure. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Raymond L. Benza participate in research or clinical trials?

Yes. Dr. Raymond L. Benza has published 210 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Raymond L. Benza's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Raymond L. Benza accept my insurance?

Dr. Raymond L. Benza accepts most major insurance plans, including Aetna and CareSource. We recommend calling the office directly at 757-388-2831 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Benza's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile